| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2003 , Vol 45 , Num 2
Triplicate Design Bioequivalence Studies
Viewed : 16192 - Downloaded : 4269